UK markets open in 1 hour 40 minutes

Aziyo Biologics, Inc. (AZYO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.98+0.28 (+4.15%)
At close: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
46,479
47,390
42,682
42,901
39,038
Cost of revenue
30,221
28,368
22,121
23,133
23,093
Gross profit
16,258
19,022
20,561
19,768
15,945
Operating expenses
Research development
10,554
9,266
4,083
2,400
2,481
Selling general and administrative
35,546
32,788
30,077
25,777
21,685
Total operating expenses
46,100
42,054
34,160
28,177
24,166
Operating income or loss
-29,842
-23,032
-13,599
-8,409
-8,221
Interest expense
5,037
5,324
5,633
5,381
5,519
Total other income/expenses net
-
3,579
-2,567
1,881
2,200
Income before tax
-34,879
-24,777
-21,799
-11,909
-11,540
Income tax expense
48
55
26
30
26
Income from continuing operations
-34,927
-24,832
-21,825
-11,939
-11,566
Net income
-34,927
-24,832
-21,825
-11,939
-11,566
Net income available to common shareholders
-34,927
-24,832
-25,335
-11,941
-11,566
Basic EPS
-
-2.38
-8.88
-1.89
-1.83
Diluted EPS
-
-2.38
-8.88
-1.89
-1.83
Basic average shares
-
10,445
2,853
6,309
6,309
Diluted average shares
-
10,445
2,853
6,309
6,309
EBITDA
-
-15,723
-12,302
-2,672
-2,202